Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
RedHill Biopharma's Opaganib Inhibits COVID-19 Variants in Preclinical Study 2021-06-28 19:00
InnoCare Announces Breakthrough Therapy Designation of Orelabrutinib by US FDA for Treatment of R/R MCL 2021-06-28 16:02
Qbiotics concludes successful $85 million capital raise 2021-06-28 09:36
CStone announces positive registrational study of GAVRETO® (pralsetinib) in Chinese patients with RET-mutant medullary thyroid cancer 2021-06-28 08:05
Sanyou Biopharmaceuticals completes series B financing and secures its leading role in innovative antibody drug discovery 2021-06-26 23:00
I-Mab Announces China NMPA Approval for Phase 1b Trial of Felzartamab in Systemic Lupus Erythematosus 2021-06-25 20:00
InnoCare Announces Approval of Initiation of Phase 1 Clinical Trial of RTK Inhibitor ICP-033 in China 2021-06-25 19:04
HistoIndex's AI-Based Digital Pathology Indicates Concomitant Histological Improvements in Liver Fat and Fibrosis in Nonalcoholic Steatohepatitis (NASH) Patients Treated with Tropifexor Compared with Placebo 2021-06-25 18:30
Lynk Pharmaceuticals Announced Clinical Approval in China of Its New Class I Drug LNK01003 2021-06-25 15:11
Zuellig Pharma Selects CYFIRMA to Elevate Cyber-intelligence Capabilities and Strengthen Cybersecurity Posture 2021-06-25 12:57
Samsung Biologics Issues Its First Annual Sustainability Report 2021-06-25 09:01
Bridge Biotherapeutics Integrates CDD Vault Collaborative Database Solution into Its R&D Platform to Harmonize Research and Drug Discovery Project Management 2021-06-25 05:57
Triastek Closes US$ 50 Million Series B Financing, Co-led by Matrix Partners China and CPE 2021-06-25 00:26
Triastek Closes US$ 50 Million Series B Financing, Co-led by Matrix Partners China and CPE 2021-06-24 20:43
Boan Biotech Publishes Research Results for CEA/CD3 Bispecific Antibody in Antibody Therapeutics 2021-06-24 14:49
China's first CAR-T Cell Therapy approved-Fosun Kite Axicabtagene Ciloleucel (FKC876) 2021-06-24 14:46
CStone announces positive GAVRETO® (pralsetinib) registrational study data for first-line treatment of advanced RET fusion-positive non-small cell lung cancer and plans to submit a new indication application 2021-06-24 08:05
Alterity Therapeutics Limited Received European Union Regulatory Guidance for ATH434 Phase 2 Clinical Trial 2021-06-23 21:21
Over a year into the global pandemic, Samsung Biologics continues to leverage innovative virtual platform for remote audits and regulatory inspections 2021-06-23 19:28
Biocytogen Completes a New Round of Financing Totaling Tens of Millions of Dollars 2021-06-23 17:02
1 237 238 239 240 241 413